Assuming multiple is required, the following results were found.

  • Aubagio (teriflunomide)

    doctor right away. What is Aubagio? Aubagio is a brand-name prescription medication. It's used to treat relapsing forms of multiple sclerosis (MS) in adults. MS is an illness in which your immune system attacks your central nervous system. Aubagio...

    https://mschristian.org/index.php/articles/2-uncategorised/8433-aubagio-teriflunomide
  • Study: Certain inflammatory demyelinating diseases belong to different category than multiple sclerosis

    Reviewed by James Ives, M.Psych. (Editor)May 19 2020 An antibody appears to make a big difference between multiple sclerosis and other disorders affecting the protective myelin sheath around nerve fibers, report Tohoku University scientists and...

    https://mschristian.org/index.php/articles/2-uncategorised/10819-study-certain-inflammatory-demyelinating-diseases-belong-to-different-category-than-multiple-sclerosis
  • Not all multiple sclerosis-like diseases are alike

    An antibody appears to make a big difference between multiple sclerosis and other disorders affecting the protective myelin sheath around nerve fibres, report Tohoku University scientists and colleagues in the journal Brain. The finding suggests that...

    https://mschristian.org/index.php/articles/2-uncategorised/10823-not-all-multiple-sclerosis-like-diseases-are-alike
  • The MS Coalition invites you to join us for the 2019 Multiple Sclerosis Summit on Saturday, November 9, 2019 at the Westin Lombard, Illinois

    2019 Multiple Sclerosis Summit Saturday, November 9, 2019 – Lombard, Illinois The MS Coalition invites you to join us for the 2019 Multiple Sclerosis Summit on Saturday, November 9, 2019 at the Westin Lombard located at 70 Yorktown Center in Lombard,...

    https://mschristian.org/index.php/component/easyblog/the-ms-coalition-invites-you-to-join-us-for-the-2019-multiple-sclerosis-summit-on-saturday-november-9-2019-at-the-westin-lombard-illinois?Itemid=341
  • B cells among factors leading to brain lesions in multiple sclerosis

    Date:Source:University of ZurichSummary:A team of researchers has shown that in multiple sclerosis, it is not only specific T cells that cause inflammation and lesions in the brain. B cells, a different type of immune cell, also play a role. These...

    https://mschristian.org/index.php/component/easyblog/b-cells-among-factors-leading-to-brain-lesions-in-multiple-sclerosis?Itemid=341
  • Multiple sclerosis: Perilous ruptures

    Date:Source:Ludwig-Maximilians-Universität MünchenSummary:The permanent neurological deficits of multiple sclerosis patients largely depend on the extent of degeneration of long nerve fibers. The latter is initiated by ruptures in the cell membrane and...

    https://mschristian.org/index.php/component/easyblog/multiple-sclerosis-perilous-ruptures?Itemid=341
  • FDA Approves Bafiertam, (a Tecfidera) Generic, for Relapsing MS

    Banner Life Sciences Announces Final FDA Approval of BAFIERTAM for Multiple Sclerosis BAFIERTAM™ (monomethyl fumarate), the bioequivalent alternative to Biogen’s Tecfidera® (dimethyl fumarate), is a new oral treatment option for relapsing forms of...

    https://mschristian.org/index.php/component/easyblog/fda-approves-bafiertam-a-tecfidera-generic-for-relapsing-ms?Itemid=341
  • Tecfidera (dimethyl fumarate)

    is Tecfidera? Tecfidera (dimethyl fumarate) is a brand-name prescription medication. It's used to treat relapsing forms of multiple sclerosis (MS). Tecfidera is classified as a disease-modifying therapy for MS. It reduces the risk of MS relapse by up to...

    https://mschristian.org/index.php/component/easyblog/tecfidera-dimethyl-fumarate?Itemid=341
  • Fooling nerve cells into acting normal

    Discovery could inform future studies related to spinal cord injuries, multiple sclerosis and epilepsy Date:Source:University of Missouri-ColumbiaSummary:Scientists have discovered that a neuron's own electrical signal, or voltage, can indicate whether...

    https://mschristian.org/index.php/component/easyblog/fooling-nerve-cells-into-acting-normal?Itemid=341
  • Blocking a molecule could delay the progression of multiple sclerosis

    Reviewed by James Ives, M.Psych. (Editor)Nov 14 2019 Over 77,000 Canadians are living with multiple sclerosis, a disease whose causes still remain unknown. Presently, they have no hope for a cure. In a study published in Science Translational Medicine,...

    https://mschristian.org/index.php/articles/2-uncategorised/9248-blocking-a-molecule-could-delay-the-progression-of-multiple-sclerosis
  • New research to stop Multiple Sclerosis - WILX-TV

    - Dr. Rany Aburashed at Memorial Healthcare in Owosso is conducting new research to potentially stop the progression of Multiple Sclerosis. A woman who witnessed the struggles of Multiple Sclerosis (MS) in a family member is now battling the disease...

    https://mschristian.org/index.php/articles/2-uncategorised/9072-new-research-to-stop-multiple-sclerosis-wilx-tv
  • Conceptual framework to study role of exercise in multiple sclerosis

    a conceptual framework for examining the relationship between exercise and adaptive neuroplasticity in the population with multiple sclerosis (MS). FULL STORY Researchers have proposed a conceptual framework for examining the relationship between...

    https://mschristian.org/index.php/component/easyblog/conceptual-framework-to-study-role-of-exercise-in-multiple-sclerosis?Itemid=341
  • Tecfidera (dimethyl fumarate)

    is Tecfidera? Tecfidera (dimethyl fumarate) is a brand-name prescription medication. It's used to treat relapsing forms of multiple sclerosis (MS). Tecfidera is classified as a disease-modifying therapy for MS. It reduces the risk of MS relapse by up to...

    https://mschristian.org/index.php/articles/2-uncategorised/8434-tecfidera-dimethyl-fumarate
  • A molecular key for delaying the progression of Multiple Sclerosis is found

    encouraging the repair of the nervous tissue, and the challenge now is to move the research forward in humans. FULL STORY Multiple Sclerosis is an autoimmune disease that attacks and destroys a structure known as the "myelin sheath," whose integrity is...

    https://mschristian.org/index.php/articles/2-uncategorised/4309-a-molecular-key-for-delaying-the-progression-of-multiple-sclerosis-is-found
  • MS genes formerly missing-in-action have been found

    Date:Source:Yale UniversitySummary:Scientists have cracked a tough nut in multiple sclerosis: where are all the genes? FULL STORY An international collaboration led by scientists at Yale has cracked a tough nut in multiple sclerosis: Where are all the...

    https://mschristian.org/index.php/component/easyblog/ms-genes-formerly-missing-in-action-have-been-found?Itemid=341
  • #ECTRIMS2019 - Longer DMT Use and Female Sex Seen to Protect Against SPMS Conversion - Multiple Sclerosis News Today

    Women with multiple sclerosis (MS), and people who stay in a relapsing stage or use disease-modifying therapies (DMTs) for longer periods are less likely to transition to secondary progressive multiple sclerosis (SPMS) than others, according to a study...

    https://mschristian.org/index.php/articles/2-uncategorised/8605-ectrims2019-longer-dmt-use-and-female-sex-seen-to-protect-against-spms-conversion-multiple-sclerosis-news-today
  • Vegetable-rich diet lowers fatigue in multiple sclerosis patients by raising good cholesterol

    Higher levels of blood high-density lipoprotein (HDL) -- or good cholesterol -- may improve fatigue in multiple sclerosis patients, according to a new University at Buffalo-led study. The pilot study, which investigated the effects of fat levels in...

    https://mschristian.org/index.php/articles/2-uncategorised/8281-vegetable-rich-diet-lowers-fatigue-in-multiple-sclerosis-patients-by-raising-good-cholesterol
  • Genentech to Present Pivotal Data for Satralizumab in Neuromyelitis Optica Spectrum Disorder and Six-year Ocrevus (Ocrelizumab) Data in Multiple Sclerosis at ECTRIMS

    (NMOSD)New data provide insights into neurofilament light chain (NfL) levels as a potential biomarker for predicting multiple sclerosis (MS) disability progression; new longer-term Ocrevus data of more than six years show reduction of disability...

    https://mschristian.org/index.php/component/easyblog/genentech-to-present-pivotal-data-for-satralizumab-in-neuromyelitis-optica-spectrum-disorder-and-six-year-ocrevus-ocrelizumab-data-in-multiple-sclerosis-at-ectrims?Itemid=341
  • Forgotten immune cells protective in mouse model of multiple sclerosis

    cells could lead to new therapies for diseases in which the immune system attacks the body's own tissues, such as multiple sclerosis and celiac disease. In the study, to be published Aug. 7 in Nature, researchers tracked immune cells in the blood of...

    https://mschristian.org/index.php/component/easyblog/forgotten-immune-cells-protective-in-mouse-model-of-multiple-sclerosis?Itemid=341
  • New app offers faster and easier assessment for multiple sclerosis

    accurate way for health care providers who don't have specialized training to assess the cognitive function of people with multiple sclerosis (MS). Multiple sclerosis is a chronic neurologic illness that affects the central nervous system, resulting in...

    https://mschristian.org/index.php/articles/2-uncategorised/8543-new-app-offers-faster-and-easier-assessment-for-multiple-sclerosis

Results 41 - 60 of 877